ArticleJHEP reports : innovation in hepatology2025
Reply to: "Comment on "Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort"".
Jisoo Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.